[1]余卓颖,杨静,蒋烨,等. 痛性及非痛性糖尿病神经病变的临床研究进展[J]. 基础医学与临床, 2023,43: 985-989. [2]Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369: m997.doi: 10.1136/bmj.m997. [3]中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 国际内分泌代谢杂志, 2021,41: 482-548. [4]尤丽丽,杨丽潇,王思瑶,等. 炎性肠病患者衰弱风险预测模型的构建及评价[J]. 基础医学与临床, 2023,43: 1127-1133. [5]谷鸿秋,周支瑞,章仲恒,等. 临床预测模型:基本概念、应用场景及研究思路[J]. 中国循证心血管医学杂志, 2018,10: 1454-1456. [6]Mao F, Zhu X, Liu S, et al. Age as an independent risk factor for diabetic peripheral neuropathy in Chinese patients with type 2 diabetes[J]. Aging Dis, 2019, 10: 592-600. [7]Stirban A. Microvascular dysfunction in the context of diabetic neuropathy[J]. Curr Diab Rep, 2014, 14: 541.doi: 10.1007/s11892-014-0541-x. [8]Khawaja N, Abu-Shennar J, Saleh M, et al. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan[J]. Diabetol Metab Syndr, 2018, 10: 8.doi: 10.1186/s13098-018-0309-6. [9]Win Mmtm, Fukai K, Nyunt HH, et al. Prevalence of peripheral neuropathy and its impact on activities of daily living in people with type 2 diabetes mellitus[J]. Nurs Health Sci, 2019, 21: 445-453. [10]Pan A, Wang Y, Talaei M, et al. Relation of active, passive, and quitting smoking with incident diabetes: a meta-analysis and systematic review[J]. Lancet Diabetes Endocrinol, 2015, 3: 958-967. [11]Cheng Y, Cao W, Zhang J, et al. Determinants of diabetic peripheral neuropathy and their clinical significance: a retrospective cohort study[J]. Front Endocrinol (Lausanne), 2022, 13:934020. doi: 10.3389/fendo.2022.934020. [12]杨灿,查何,丁飞. 老年2型糖尿病及并发症与糖化血红蛋白的相关性[J]. 中国老年学杂志, 2018,38: 5437-5438. [13]Iqbal Z, Bashir B, Ferdousi M, et al. Lipids and peripheral neuropathy[J]. Curr Opin Lipido, 2021, 32: 249-257. [14]Tang WHW, Maroo A, Young JB. Ischemic heart disease and congestive heart failure in diabetic patients[J]. Med Clin North Am, 2004, 88: 1037-1061. [15]Fishman SL, Sonmez H, Basman C, et al. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review[J]. Mol Med, 2018, 24: 59.doi: 10.1186/s10020-018-0060-3. |